Javier Donate-Correa
Overview
Explore the profile of Javier Donate-Correa including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
53
Citations
943
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Siverio-Morales O, Mora-Fernandez C, Hernandez-Carballo C, Martin-Nunez E, Gonzalez-Luis A, Martin-Olivera A, et al.
Am J Physiol Heart Circ Physiol
. 2024 Nov;
328(1):H14-H20.
PMID: 39560964
The triglyceride-glucose (TyG) index has been proposed as an independent predictor of coronary artery disease (CAD). In this retrospective study, we further examine this association and its utility as a...
2.
Donate-Correa J, Ferri C, Mora-Fernandez C, Perez-Delgado N, Gonzalez-Luis A, Navarro-Gonzalez J
Cardiovasc Diabetol
. 2024 Aug;
23(1):314.
PMID: 39182114
Background: Diabetic kidney disease (DKD) is associated with a higher risk of cardiovascular disease (CVD). Pentoxifylline (PTF), a nonselective phosphodiesterase inhibitor with anti-inflammatory, antiproliferative, and antifibrotic actions, has demonstrated renal...
3.
Donate-Correa J, Gonzalez-Luis A, Diaz-Vera J, Hernandez-Fernaud J
World J Diabetes
. 2024 Aug;
15(7):1398-1403.
PMID: 39099820
Diabetic kidney disease (DKD) is one of the complications of diabetes, affecting millions of people worldwide. The relentless progression of this condition can lead to kidney failure, requiring life-altering interventions...
4.
Donate-Correa J, Martin-Nunez E, Hernandez-Carballo C, Gonzalez-Luis A, Mora-Fernandez C, Martin-Olivera A, et al.
Int J Mol Sci
. 2024 May;
25(10).
PMID: 38791495
Fibroblast growth factor 23 (FGF23) levels are often elevated in chronic kidney disease (CKD). FGF23 and inflammation are common characteristics in CKD, and both are associated with worse disease progression...
5.
Donate-Correa J, Martin-Nunez E, Mora-Fernandez C, Gonzalez-Luis A, Martin-Olivera A, Navarro-Gonzalez J
Int J Mol Sci
. 2023 Sep;
24(18).
PMID: 37762433
In this cross-sectional study, we evaluated the associations of inflammation and hemoglobin with coronary artery disease (CAD) in subjects with type 2 diabetes mellitus (T2DM) and preserved kidney function. We...
6.
Donate-Correa J, Martin-Nunez E, Mora-Fernandez C, Gonzalez-Luis A, Martin-Olivera A, Navarro-Gonzalez J
Int J Mol Sci
. 2023 Sep;
24(17).
PMID: 37686263
Circulating Klotho levels are significantly reduced in subjects with type 2 diabetes mellitus (T2DM) and in kidney disease patients. In this work, the relationship between Klotho levels and the coronary...
7.
Martin-Carro B, Donate-Correa J, Fernandez-Villabrille S, Martin-Virgala J, Panizo S, Carrillo-Lopez N, et al.
Int J Mol Sci
. 2023 Jun;
24(12).
PMID: 37373455
Preclinical biomedical models are a fundamental tool to improve the knowledge and management of diseases, particularly in diabetes mellitus (DM) since, currently, the pathophysiological and molecular mechanisms involved in its...
8.
Donate-Correa J, Martin-Nunez E, Martin-Olivera A, Mora-Fernandez C, Tagua V, Ferri C, et al.
Front Endocrinol (Lausanne)
. 2023 Jun;
14:1146012.
PMID: 37274332
Introduction: Klotho protein is predominantly expressed in the kidneys and has also been detected in vascular tissue and peripheral blood circulating cells to a lesser extent. Carotid artery intima-media thickness...
9.
Martin-Carro B, Martin-Virgala J, Fernandez-Villabrille S, Fernandez-Fernandez A, Perez-Basterrechea M, Navarro-Gonzalez J, et al.
Int J Mol Sci
. 2023 Mar;
24(6).
PMID: 36982322
Fibrosis plays an important role in the pathogenesis of long-term diabetic complications and contributes to the development of cardiac and renal dysfunction. The aim of this experimental study, performed in...
10.
Mora-Fernandez C, Sanchez-Nino M, Donate-Correa J, Martin-Nunez E, Perez-Delgado N, Valino-Rivas L, et al.
Biomed Pharmacother
. 2023 Mar;
154:113677.
PMID: 36942605
Sodium-glucose co-transporter-2 inhibitors (SGLT2i) provide cardiorenal protection. However, the molecular mechanisms remain poorly understood. We explored the impact of SGLT2i on Klotho, a kidney-derived protein with antiaging, renal-protective and heart-protective...